Sexually Transmitted Diseases in Pregnancy

The Sexually Transmitted Infections Are Transmitted From Person To Person By Sexual, From Mother To Child (Pregnancy And Childbirth) And Intravenously. The Enlightenment Of Doctor Maria Jose Rego De Sousa.

The infection results from tissue invasion of a host organism by external agents (bacteria), whose multiplication and reaction of the tissues of the host to the same and to toxins produced by them cause diseases commonly referred to as sexually transmitted diseases (STDS).

Chlamydia is a sexually transmitted Infection (STI) caused by the bacteria Chlamydia trachomatis and can be transmitted by sexual contact or from mother to child during childbirth. The patients infected with chlamydia are often asymptomatic, and the infection go unnoticed and untreated, which can lead to various complications such as pelvic disease, infertility (http://prozipcodes.com/2015/01/what-is-infertility/) and complications during pregnancy. About 20% of women present nonspecific symptoms such as vaginal discharge, burning and frequent urination.

The main complication of infection by Chlamydia is the progression of bacteria toward the uterus, fallopian tubes and ovaries, causing a serious infection designated pelvic inflammatory disease, which in severe cases can lead to infertility, ectopic pregnancy or tubal occlusion and chronic pelvic pain.

In pregnant women, chlamydia infections can lead to premature birth and the baby present the same infection and develop early disease such as pneumonia and conjunctivitis.

The STDS are a public health problem, for which the screening is crucial. Has as main objective to identify and treat people infected to prevent complications and reinfeções, as well as the research around new diagnostic methodologies. All pregnant women should do the screening for this infection during the second trimester of pregnancy, according to the General Direction of health.

Many of the microorganisms of STIs are not detected by usual methods (serologyand culture). New molecular biology techniques on samples of urine and genital exudates, enable breakthroughs in the diagnosis today.

Detection of Chlamydia is performed through the PCR technique (Polymerase chain reaction), which will analyze a sample of urine or material collected for screeningfor the presence of DNA of chlamydia in vaginal secretions or urine.

The amplified product is made possible by the use of a new technology platformbased on low-density arrays: CLART ® (Clinical Array Technology). This type of methodology allows detection of microorganisms (coinfeção) also involved in these infections as Neisseria gonorrhoeae and Mycoplasma.